SABiosciences Corp. – Trademark Portfolio
Entity Type: 03
SABiosciences Corp. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 7 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include RT2, CIGNAL, QBIOMARKER, and RT2 PROFILER. The owner is based in Frederick, MD.
6951 Executive Way
Frederick, MD 21703
Showing of trademarks Trademarks
Trademark Classifications
SABiosciences Corp.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does SABiosciences Corp. have?
SABiosciences Corp. has 7 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 abandoned.
What trademark classes does SABiosciences Corp. file in?
SABiosciences Corp. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are SABiosciences Corp.'s most well-known trademarks?
SABiosciences Corp.'s registered trademark portfolio includes well-known marks such as RT2, CIGNAL, QBIOMARKER, and RT2 PROFILER. These are among 4 currently registered trademarks in the portfolio.
What is SABiosciences Corp.'s trademark registration success rate?
SABiosciences Corp. has a 57% trademark registration rate, with 4 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.